Invest in better immunocontraception with pZP vaccine
Proof of concept complete with over eight studies demonstrating fertility control in wildlife field trials
Clear development pathway
EPA approval expected by 1Q 2019
Revenue can be generated quickly
Positive ROI and ROE
Commercial-ready in one year from closing on funding means cashflow can fund life-cycle management and portfolio expansion to develop vaccines for other species without need for additional dilutive funding
Immunocontraception has immediate application in control of overabundant wild horse populations and urban deer.
Use of Proceeds and Development Plan
USE OF PROCEEDS:
Create, standardize and validate manufacturing protocol
Compile submission dossier for EPA
QA:Manufacture batches to affirm antibody response and release specs
Field testing of SpayVac immunocontraception with potential customers
Vaccination of additional overabundant species to expand usage to a greater number of species
Develop other immunocontraceptive vaccines for feral cats and feral dogs
Set up long-term production facility
We are seeking investors
SpayVac for Wild seeks investors and partners
We are ambitious and would like to fund as much development as possible into pZP immunocontraception and other methods of immunocontraception. Please contact us if you are interested in being part of this exciting opportunity.
To receive a non-confidential slide deck, email us
SpayVac for Wildlife Inc.
8617 Lochside Drive, North Saanich, BC V8L1M8, CA & 725 University Row, Suite 439, Madison, WI, 53705 USA